Peptide dosing
With peptides and GLP-1 medications, dose is most of the story: how much, how often, how to step up without inviting side effects, and how to reconstitute a vial correctly. These articles collect what we've written on peptide dosing — titration schedules, injection frequency, microdosing debates, and technique.
One thing you won't find is a personal protocol: that's your prescriber's job. Every Promise treatment comes with provider oversight, and dosing decisions belong in that conversation. Where a compound has its own dosing article, you'll find the specifics there.
19 articles on this topic
-

How to Inject Semaglutide Safely
Semaglutide goes into the fatty layer beneath the skin of the abdomen, front of the thigh, or back of the upper arm. The device and pharmacy label—not a generic online diagram—determine the exact technique and measured amount.
-

Thymosin Alpha-1 Dosage: What Trials Used
Published thymalfasin protocols range from 1.6 mg twice weekly for months in hepatitis studies to every-12-hour hospital regimens in sepsis. Those trial schedules explain the numbers online; they are not a personal dosing plan.
-

DSIP Dosage: What the Human Studies Used
There is no standard clinical dose for delta sleep-inducing peptide. The small human studies used intravenous infusions under observation, not a validated at-home schedule.
-

Tirzepatide Units to Mg: The Safe Conversion
Tirzepatide units to mg is not a fixed conversion. On a U-100 syringe, 20 units is 0.2 mL; the milligram amount depends on the vial concentration.
-

KLOW Peptide Dosage: Why the Blend Is Dosed as One
There is no universal dose for KLOW. Its four peptides come in one fixed-ratio vial, so a prescriber adjusts the finished blend rather than setting four separate component doses.
-

Microdosing Semaglutide: What the Evidence Says
A slower climb can be a tolerability strategy. Staying indefinitely on a fraction of a studied dose is a different idea, and the evidence for it is not there yet.
-

Tesamorelin Dosage: How Prescribers Set It
Tesamorelin is dosed daily in the trials and current brand label, but the milligram amount depends on the formulation. IGF-1, glucose, indication and tolerability matter more than a copied schedule.
-

BPC-157 and TB-500 Dosage: What Evidence Shows
There is no established human dosing standard for BPC-157, TB-500, or their combination. Published figures come mostly from animals or studies of different molecules and routes.
-

PT-141 Dosage: What Trials and the Label Used
PT-141 is studied and labeled as an as-needed medication, not a daily routine. The practical variables are the prescribed amount, timing before anticipated activity, tolerability, and safe spacing between doses.
-

CJC 1295 Ipamorelin Dosage: What Studies Used
There is no validated combined dose. Human studies used different formulations, routes and objectives, so a prescriber has to identify the exact product, interpret the clinical context and set the schedule.
-

Sermorelin Dosing: How Prescribers Set a Dose
There is no single established adult dose. Nighttime is common because sermorelin works through the body's pulsatile growth-hormone system, while the amount and titration depend on the person, the formulation and the prescriber's clinical judgment.
-

Where to Inject Tirzepatide: Abdomen, Thigh, Arm
Current Zepbound and Mounjaro labels name three subcutaneous areas: the abdomen, thigh, and back of the upper arm. This overview does not replace the product-specific instructions from the prescriber and dispensing pharmacy.
-

MOTS-c Dosage: Why There Is No Standard Dose
There is no established human MOTS-c dose. Published human research is mostly observational, and the numbers repeated online come largely from mouse experiments rather than clinical dosing trials.
-

Microdosing Tirzepatide: What It Means
No trial has ever tested it, and the term has no clinical definition. That does not make it unreasonable — but it does change what you can honestly expect from it.
-

Semaglutide Dosage: The 17-Week Ladder
The weight-management schedule climbs through five doses over sixteen weeks before reaching 2.4 mg. That deliberate pace is the single best-supported way to make the first months tolerable.
-

Tirzepatide Dosage and the Titration Ladder
Every tirzepatide dose ladder starts at 2.5 mg and climbs in 2.5 mg steps no sooner than every four weeks. Understanding why that interval exists tells you most of what you need to know about your own schedule.
-

How to Reconstitute Peptides, Step by Step
What reconstitution involves, how the standard mixing technique works, and why your pharmacy's product-specific instructions govern every step.
-

CJC-1295 and Ipamorelin: Why They're Paired
One prescription, two receptors: CJC-1295 signals through the GHRH receptor while ipamorelin mimics ghrelin at GHSR-1a — two separate inputs to the same growth-hormone axis.
-

A Patient's Guide to NAD+ Injections
NAD+ is a coenzyme found in every living cell, yet most human trial data comes from oral precursors like NR and NMN — including a 2025 meta-analysis in adults with mean ages of 61 to 83 that found no significant muscle benefit.